Marvell COO trust sells 10K shares at $203

Marvell’s President and COO, via a family trust, executed a 10,000‑share Rule 10b5-1 plan sale and now indirectly holds 217,941 MRVL shares.

Rhea-AI Filing Summary

Marvell Technology, Inc. (MRVL) reports that President and COO Chris Koopmans, through the Christopher R. Koopmans and Heather J. Koopmans Family Trust, sold 10,000 shares of common stock on September 1, 2026 at a weighted average price of $203.27 per share. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on January 5, 2026. Following this transaction, the trust holds 217,941 shares of Marvell common stock indirectly.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Koopmans Chris

Role President and COO

Sold 10,000 shs ($2.03M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2, F3	10,000	$203.27	$2.03M

Holdings After Transaction: Common Stock — 217,941 shares (Indirect, By Trust)

Footnotes (3)

1. F1. Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on January 5, 2026.
2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices rounded to the nearest cent ranging from $200.72 to $206.18, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
3. F3. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $203.27 per share Sale price range: $200.72–$206.18 per share +2 more

5 metrics

Shares sold 10,000 shares Common stock sale on September 1, 2026 by family trust

Weighted average sale price $203.27 per share Average price for the 10,000 MRVL shares sold

Sale price range $200.72–$206.18 per share Range of prices for multiple transactions included in the sale

Shares held after transaction 217,941 shares Indirect holdings by the family trust following the sale

Rule 10b5-1 plan adoption date January 5, 2026 Trading plan under which the September 1, 2026 sale was executed

Key Terms

Rule 10b5-1 Plan, weighted average price, indirect, Family Trust

4 terms

Rule 10b5-1 Plan regulatory

"Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average price financial

"The price reported is a weighted average price. These shares were sold"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

indirect financial

"The filing classifies the ownership as indirect with nature of ownership"

Family Trust financial

"Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MRVL report for President and COO Chris Koopmans?

Marvell reported that President and COO Chris Koopmans, via a family trust, sold 10,000 shares of MRVL common stock on September 1, 2026 in an open-market or private transaction under a Rule 10b5-1 trading plan.

At what price were the 10,000 MRVL shares sold in this Form 4 filing?

The filing reports a weighted average price of $203.27 per share. Footnotes state the shares were sold in multiple transactions at prices, rounded to the nearest cent, ranging from $200.72 to $206.18 per share.

How many MRVL shares does Chris Koopmans indirectly hold after this sale?

After the reported sale, the family trust associated with Chris Koopmans holds 217,941 shares of Marvell common stock indirectly. The filing identifies the holder as the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Was the MRVL insider sale by Chris Koopmans under a Rule 10b5-1 plan?

Yes. A footnote states the sales were made pursuant to a Rule 10b5-1 Plan adopted by the reporting person on January 5, 2026, and the filing’s Rule 10b5-1 checkbox is affirmed.

Who legally holds the MRVL shares involved in this Form 4 transaction?

The shares are held indirectly, identified as “Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.” The filing classifies the ownership as indirect with nature of ownership “By Trust.”

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:22 PM EDT Accepted by SEC EDGAR 09/02/2026 - 04:21 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koopmans Chris

(Last) (First) (Middle)

5488 MARVELL LANE

(Street)

SANTA CLARA CALIFORNIA 95054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		S(1)		10,000	D	$203.27(2)	217,941	I	By Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on January 5, 2026.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices rounded to the nearest cent ranging from $200.72 to $206.18, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

3. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Remarks:

	Christopher Koopmans by Blair Walters as Attorney-in-Fact	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)